Status:
public
Videos: (
0
) Documents: (
0
) Comments: (
0
)
Group description
In immunology, activation is the transition of leucocytes and other cell types involved in the immune system. On the other hand, deactivation is the transition in the reverse direction.
Group Videos
No videos have been added jet. You may join this group and add yours now.
Group Documents
No documents have been added jet. You may join this group and add yours now.
News
- Duration of RBC storage does not affect short-term pulmonary, immunologic, or coagulation status
( American Thoracic Society ) There is no difference in early measures of pulmonary function, immunologic status or coagulation status after fresh versus standard issue single-unit red blood cell transfusion, according to a new study from the Mayo Clinic. - RBC Storage Not Associated with Short-Term Complications
There is no difference in early measures of pulmonary function, immunologic status or coagulation status after fresh versus standard issue single-unit red blood cell (RBC) transfusion, according to a new study from the Mayo Clinic. - PV-10 Mechanism of Action Data to Be Presented at the Society of Surgical Oncology Annual Meeting March 21-24, 2012 in ...
Provectus Pharmaceuticals, Inc. , a development-stage oncology and dermatology biopharmaceutical company, announces that nonclinical data on the immunologic mechanism of action of PV-10 will be presented at the Society of Surgical Oncology Annual Meeting, March 21-24, 2012, at the Orlando World Center Marriott in Orlando, Florida. - RBC storage duration not associated with transfusion-related pulmonary complications
There is no difference in early measures of pulmonary function, immunologic status or coagulation status after fresh versus standard issue single-unit red blood cell (RBC) transfusion, according to a new study from the Mayo Clinic. - OncoSec Initiates Phase II Merkel Cell Carcinoma Study and Doses Several Patients
SAN DIEGO, Feb. 13, 2012 /PRNewswire/ --Â OncoSec Medical Incorporated (OTCBB: ONCS.OB - News), which is developing its advanced-stage OncoSec Medical System (OMS) ElectroOncology therapies to treat solid tumor ... - Press Release
Provectus Pharmaceuticals Inc. Posted on:18 Jan 12 Provectus Pharmaceuticals, Inc. (OTCBB: PVCT, http://www.pvct.com ), a development-stage oncology and dermatology biopharmaceutical company, announces that nonclinical data on the immunologic mechanism of action of PV-10 will be presented at the Society of Surgical Oncology Annual Meeting, March 21-24, 2012, at the Orlando World Center ... - Personalized Medicine - Scientific & Commercial Aspects
NEW YORK, Feb. 1, 2012  /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue: Personalized Medicine - scientific & commercial aspects http://www.reportlinker.com/p0203549/Personalized-Medicine---scientific--commercial-aspects.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=GenomicsThe ... - Argos Therapeutics Announces New Data Demonstrating Prolonged Overall Survival in a Phase 2 Study of its Arcelis™ ...
DURHAM, N.C., Feb. 4, 2012 /PRNewswire/ -- Argos Therapeutics Inc. today announced that updated results from an open label Phase 2 study of its Arcelis™ immunotherapy, AGS-003, in combination with sunitinib ... - T2 Biosystems Announces Issuance of Key Patent Providing Broad Intellectual Property Protection for Direct Detection ...
T2 Biosystems, a company developing direct detection products enabling superior diagnostics, today announced the issuance of patent number 8,102,176 by the United States Patent and Trademark Office entitled “NMR Device for Detection of Analytes”. - OncoSec to commence OMS ElectroImmunotherapy Phase II trial in MCC
OncoSec Medical Incorporated, which is developing its advanced-stage OncoSec Medical System (OMS) ElectroOncology therapies to treat solid tumor cancers, today announced that physicians at the University of Washington and Seattle Cancer Care Alliance in conjunction with the Fred Hutchinson Cancer Center, have treated several patients in an open-label Phase II clinical trial evaluating OncoSec's ...
Related on Wikipedia
- Immunology - Wikipedia, the free encyclopedia
Immunology is a broad branch of biomedical science that covers the study of all aspects of the immune system in all organisms It deals with the physiological functioning of the ... - Immunologic adjuvant - Wikipedia, the free encyclopedia
In immunology, an adjuvant is an agent that may stimulate the immune system and increase the response to a vaccine, without having any specific antigenic effect in itself. The ... - Immune system - Wikipedia, the free encyclopedia
An immune system is a system of biological structures and processes within an organism that protects against disease. In order to function properly, an immune system must ... - Transplant rejection - Wikipedia, the free encyclopedia
Transplant rejection occurs when transplanted tissue is rejected by the recipient's immune system, which destroys the transplanted tissue. Transplant rejection can be lessened ... - Adjuvant - Wikipedia, the free encyclopedia
An adjuvant (from Latin, adiuvare: to aid) is a pharmacological or immunological agent that modifies the effect of other agents, such as a drug or vaccine. - Central tolerance - Wikipedia, the free encyclopedia
Central tolerance is the mechanism by which newly developing T cells and B cells are rendered non-reactive to self. The concept of central tolerance was proposed in 1959 by ... - Hemagglutinin - Wikipedia, the free encyclopedia
Hemagglutinin or haemagglutinin (British English) refers to a substance that causes red blood cells to agglutinate. This process is called hemagglutination or haemagglutination. - Agglutination (biology) - Wikipedia, the free encyclopedia
Agglutination is the clumping of particles. The word agglutination comes from the Latin agglutinare, meaning "to glue." This occurs in biology in three main examples: - Serology - Wikipedia, the free encyclopedia
Serology is the scientific study of blood serum and other bodily fluids. In practice, the term usually refers to the diagnostic identification of antibodies in the serum. Such ... - Radioimmunoassay - Wikipedia, the free encyclopedia
Radioimmunoassay (RIA) is a very sensitive in vitro assay technique used to measure concentrations of antigens (for example, hormone levels in the blood) by use of antibodies.